|
|
||||||||
We have investigated the effects of monosodium glutamate (MSG) lesioning of the arcuate nucleus on both central and peripheral components of the hypothalamo-pituitary-adrenocortical (HPA) axis under basal conditions and under acute and chronic stress. Plasma ACTH levels were lower in MSG-lesioned rats (27 ± 7 pg/ml) compared with controls (71 ± 18 pg/ml) while corticosterone levels were elevated (523 ± 84 ng/ml compared with 176 ± 34 ng/ml). Quantititative in situ hybridization histochemistry revealed that corticotrophin-releasing factor mRNA levels in the medial parvocellular part of the hypothalamic paraventricular nucleus were significantly lower in MSG-treated rats. MSG lesioning resulted in an enhanced response of corticosterone to restraint stress (1309 ± 92 ng/ml compared with 628 ± 125 ng/ml in sham-lesioned animals), while ACTH responses to restraint stress in MSG-lesioned and sham-MSG groups were not significantly different (160 ± 24 pg/ml and 167 ± 24 pg/ml respectively). These data suggest that MSG-lesioned rats have an increased adrenocortical sensitivity. In rats subjected to the chronic osmotic stimulus of drinking 2% saline for 12 days, plasma ACTH levels were significantly reduced (15 ± 5 pg/ml) and the ACTH and corticosterone responses to restraint stress were eliminated. ACTH levels were also reduced in MSG-treated animals given 2% saline and the ACTH response to acute stress remained absent in these animals. However, a robust corticosterone response to restraint stress was observed in saline-treated MSG-lesioned rats. These data demonstrate that MSG lesioning results in elevated basal and stress-induced plasma corticosterone, and restores the adrenocortical response to stress which is absent in chronically osmotically stimulated rats. The evidence is consistent with the suggestion that MSG lesions a pathway involved in tonic inhibition of the HPA axis. In addition, the adrenocortical sensitivity to ACTH and other secretagogues may be increased in MSG-treated animals.
Journal of Endocrinology (1994) 141, 497–503
This article has been cited by other articles:
![]() |
S.A. Hesketh, J.D. Leggett, and D.S. Jessop Henry Chronic citalopram treatment does not sensitize the adrenal gland to ACTH (1 24) in rats J Psychopharmacol, November 1, 2007; 21(8): 885 - 887. [Abstract] [PDF] |
||||
![]() |
S Hesketh, D S Jessop, S Hogg, and M S Harbuz Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress J. Endocrinol., June 1, 2005; 185(3): 373 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Evans, C. W. Wilkinson, K. Bentson, P. Gronbeck, A. Zavosh, and D. P. Figlewicz PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1426 - R1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bell, S. Bhatnagar, S. F. Akana, S. Choi, and M. F. Dallman Disruption of Arcuate/Paraventricular Nucleus Connections Changes Body Energy Balance and Response to Acute Stress J. Neurosci., September 1, 2000; 20(17): 6707 - 6713. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bowers, W. E. Cullinan, and J. P. Herman Region-Specific Regulation of Glutamic Acid Decarboxylase (GAD) mRNA Expression in Central Stress Circuits J. Neurosci., August 1, 1998; 18(15): 5938 - 5947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |